In the attempt to identify classic driver mutations in B cell malignancy such as IDH in AML or glioma, recent sequencing approaches have not revealed similarly prominent metabolism genes as direct driver mutations of lymphomas [26,27]. This evidence concerns the gene IDH2 and acute myeloid leukemia.